Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
Abstract The first synthetic cannabinoid receptor agonists (SCRAs) were designed as tool compounds to study the endocannabinoid system’s two predominant cannabinoid receptors, CB1R and CB2R. Unfortunately, novel SCRAs now represent the most rapidly proliferating novel psychoactive substances (NPS) o...
Enregistré dans:
Auteurs principaux: | Ayat Zagzoog, Asher L. Brandt, Tallan Black, Eunhyun D. Kim, Riley Burkart, Mikin Patel, Zhiyun Jin, Maria Nikolaeva, Robert B. Laprairie |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b6aa1fa4ea2b4839a0bdba526e98a3e7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
par: Ayat Zagzoog, et autres
Publié: (2020) -
1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
par: Amer H. Tarawneh, et autres
Publié: (2022) -
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease.
par: Natalia Battista, et autres
Publié: (2013) -
The natural product magnolol as a lead structure for the development of potent cannabinoid receptor agonists.
par: Alexander Fuchs, et autres
Publié: (2013) -
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
par: Marjolein Soethoudt, et autres
Publié: (2017)